Objective Patients with lupus erythematosus (LE) are at heightened risk for clinical events,
chiefly heart attacks and strokes, from atherosclerotic cardiovascular disease (ASCVD). We …

Objective Patients with lupus erythematosus (LE) are at heightened risk for clinical events,
chiefly heart attacks and strokes, from atherosclerotic cardiovascular disease (ASCVD). We …

Background: Cardiovascular disease (CVD) is a leading cause of morbidity and mortality in
systemic lupus erythematosus (SLE). 1 Patients with SLE have a 2-to 10-fold higher risk of …

Sachs (1) described an association between a form of “atypical verrucous endocarditis” and
“lupus erythematosus disseminates,” now known as systemic lupus erythematosus (SLE) …

Background Systemic lupus erythematosus (SLE) is an autoimmune disease that typically
affects women aged 16–55 years. Cardiovascular disease (CVD) is a well-recognized …

Background Cardiovascular disease represents an important cause of morbidity and
mortality in patients with a diagnosis of systemic lupus erythematosus (SLE), due to a …

Systemic lupus erythematosus (SLE) is a highly variable autoimmune disease characterized
by aberrant host-immune responses and chronic inflammation. Recently, a strong …

Background Autoimmune disease such as systemic lupus erythematosus (SLE) and
psoriasis have been previously associated with an increased risk of atherosclerotic …

Women with lupus between the ages of 35–44 years have been shown to have a 50-fold
increased risk of myocardial infarction compared with an age-matched cohort. 1 Despite this …

Background Systemic lupus erythematosus (SLE) is an autoimmune disease that has a
higher prevalence in the young female population. The presentation of SLE can vary from …